Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Sweeney, M.B.B.S.
Hoosier Oncology Group, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Chicago
Chicago, Illinois, United States
- Medical & Surgical Specialists, Llc
Galesburg, Illinois, United States
- Oncology Hematology Associates of Sw Indiana
Evansville, Indiana, United States
- Fort Wayne Oncology & Hematology, Inc
Fort Wayne, Indiana, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Quality Cancer Center (mcgop)
Indianapolis, Indiana, United States
- Arnett Cancer Care
Lafayette, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Ap&s Clinic
Terre Haute, Indiana, United States
- Siteman Cancer Center
St Louis, Missouri, United States
- Oncology Hematology Care, Inc.
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2005
- Primary completion
- 31 Dec 2008
- Completion
- 31 Dec 2008
- Last update posted
- 14 Mar 2016
- Registered enrollment
- 45
- Registry id
- NCT00234494
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.